GlassScriptPhysician profile
Spencer A Colden
NPI 1336127497
$774.82
in general payments reported to CMS, 2019-2025
6 companies · $376 in 2025
The $376 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.04 · 2020: $17.42 · 2022: $149 · 2023: $148 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $524.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $296.89 | 2022-2023 | Nexlizet, Nexletol |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $251.54 | 2025 | Caplyta |
| Axsome Therapeutics, INC. | $124.93 | 2025 | Symbravo |
| Heron Therapeutics, INC. | $49.61 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $34.84 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $17.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Spencer Colden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.